{"id":"W4387809552","doi":"10.1016/j.annonc.2023.10.050","title":"LBA1 CheckMate 77T: Phase III study comparing neoadjuvant nivolumab (NIVO) plus chemotherapy (chemo) vs neoadjuvant placebo plus chemo followed by surgery and adjuvant NIVO or placebo for previously untreated, resectable stage II–IIIb NSCLC","year":2023,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Esophageal Cancer Research and Treatment","field":"Medicine","cited_by":100,"is_retracted":false,"has_abstract":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Placebo; Nivolumab; Chemotherapy; Adjuvant; Neoadjuvant therapy; Internal medicine; Oncology; Cancer; Immunotherapy; Breast cancer; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002559515,0.0008346444,0.003424184,0.000629925,0.0005273331,0.00006931446,0.0004228621,0.0004052719,0.0004267329],"category_scores_gemma":[0.0005505746,0.000680741,0.0004617331,0.000970356,0.0003832762,0.0002823136,0.0003993838,0.0005800034,0.00003623528],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008329873,"about_ca_system_score_gemma":0.002319676,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002998204,"about_ca_topic_score_gemma":0.001564802,"domain_scores_codex":[0.9938334,0.0003480144,0.001493403,0.00134817,0.0009193745,0.002057644],"domain_scores_gemma":[0.9954333,0.001433779,0.0007097659,0.0009745435,0.0005510517,0.0008975631],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.5196329,0.01236282,0.02576594,0.002579772,0.005561684,0.006915177,0.01020033,0.0001930256,0.01078048,0.0000461595,0.2957674,0.1101943],"study_design_scores_gemma":[0.6428173,0.1132495,0.008022869,0.00200412,0.001644969,0.0006306762,0.008467634,0.01687902,0.1279549,0.0001264792,0.0757306,0.002471999],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9784734,0.007409121,0.0000523216,0.004152952,0.0002624832,0.007904217,0.0002890639,0.000333903,0.001122583],"genre_scores_gemma":[0.9761928,0.004935836,0.0001871591,0.0007290284,0.0002122002,0.001532874,0.0005497575,0.0001837588,0.01547653],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2200367,"threshold_uncertainty_score":0.9995643,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1174064700800924,"score_gpt":0.4261141496413201,"score_spread":0.3087076795612277,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}